Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 6 | $71,413 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
06 Mar 2025 16:27 | KPTI | Karyopharm Therapeutics Inc | CHENG SOHANYA ROSHAN | EVP & Chief Commercial Officer | 04 Mar 2025 | Sale | 3,445 | 6.29 | 21,669 | D |
05 Sep 2024 16:13 | KPTI | Karyopharm Therapeutics Inc | CHENG SOHANYA ROSHAN | EVP & Chief Commercial Officer | 04 Sep 2024 | Sale | 5,356 | 0.7218 | 3,866 | D |
04 Mar 2024 19:37 | KPTI | Karyopharm Therapeutics Inc | CHENG SOHANYA ROSHAN | EVP & Chief Commercial Officer | 01 Mar 2024 | Sale | 5,109 | 1.2 | 6,131 | D |
04 Mar 2024 19:37 | KPTI | Karyopharm Therapeutics Inc | CHENG SOHANYA ROSHAN | EVP & Chief Commercial Officer | 29 Feb 2024 | Sale | 21,840 | 1.17 | 25,553 | D |
05 Sep 2023 16:27 | KPTI | Karyopharm Therapeutics Inc | CHENG SOHANYA ROSHAN | EVP & Chief Commercial Officer | 01 Sep 2023 | Sale | 7,415 | 1.3313 | 9,872 | D |
12 Jun 2023 16:07 | KPTI | Karyopharm Therapeutics Inc | CHENG SOHANYA ROSHAN | EVP & Chief Commercial Officer | 08 Jun 2023 | Sale | 1,839 | 2.35 | 4,322 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)